本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vera Therapeutics, Inc.

21.34
-1.2300-5.45%
盘后21.340.00000.00%18:26 EDT
成交量:172.52万
成交额:3,762.85万
市值:13.62亿
市盈率:-5.94
高:22.77
开:22.56
低:21.30
收:22.57
52周最高:51.61
52周最低:18.53
股本:6,382.37万
流通股本:4,291.91万
量比:0.85
换手率:4.02%
股息:- -
股息率:- -
每股收益(TTM):-3.5921
每股收益(LYR):-2.7500
净资产收益率:-54.83%
总资产收益率:-30.24%
市净率:2.91
市盈率(LYR):-7.76

数据加载中...

2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

重要事件披露

Form 8-K - Current report
2024/02/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/29

重要事件披露

Form 8-K - Current report